Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
16.45
+0.63 (3.98%)
At close: Mar 4, 2026, 4:00 PM EST
16.42
-0.03 (-0.18%)
Pre-market: Mar 5, 2026, 4:00 AM EST
Hims & Hers Health Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Hims & Hers Health stock have an average target of 26.38, with a low estimate of 13.25 and a high estimate of 68. The average target predicts an increase of 60.36% from the current stock price of 16.45.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Hims & Hers Health stock from 13 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Hold | 8 | 8 | 7 | 8 | 9 | 9 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 12 | 12 | 12 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $48 → $25 | Buy | Maintains | $48 → $25 | +51.98% | Feb 25, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $40 → $21 | Hold | Maintains | $40 → $21 | +27.66% | Feb 25, 2026 |
| Leerink Partners | Leerink Partners | Hold Maintains $20 → $18 | Hold | Maintains | $20 → $18 | +6.38% | Feb 24, 2026 |
| BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Feb 24, 2026 |
| Citigroup | Citigroup | Strong Sell Maintains $17 → $13 | Strong Sell | Maintains | $17 → $13 | -19.45% | Feb 24, 2026 |
Financial Forecast
Revenue This Year
2.80B
from 2.35B
Increased by 19.27%
Revenue Next Year
3.30B
from 2.80B
Increased by 17.96%
EPS This Year
0.55
from 0.51
Increased by 6.60%
EPS Next Year
0.71
from 0.55
Increased by 29.73%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 3.0B | 3.7B | |||
| Avg | 2.8B | 3.3B | |||
| Low | 2.4B | 2.7B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 26.6% | 33.3% | |||
| Avg | 19.3% | 18.0% | |||
| Low | 3.0% | -4.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 1.28 | 1.03 | ||
| Avg | 0.55 | 0.71 | ||
| Low | -0.05 | 0.21 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 150.1% | 88.4% | ||
| Avg | 6.6% | 29.7% | ||
| Low | - | -62.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.